• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Get started
Sign in
Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

by Truveta Staff | May 19, 2023 | Technology

The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on MedRxiv, which investigated speech delays in children under age 5 as an unexpected outcome...
From questions to answers: How Truveta Studio was used to create rapid heart health equity insights in just a few weeks

From questions to answers: How Truveta Studio was used to create rapid heart health equity insights in just a few weeks

by Truveta Staff | Feb 14, 2023 | Technology

It’s no secret — yet surprising and tragic — that the United States is one of the most dangerous high-income countries in which to give birth. It’s also unfortunately well known that nearly every maternal health outcome in the United States negatively affects women of...
Preeclampsia-related heart failure disproportionately impacts Black mothers

Preeclampsia-related heart failure disproportionately impacts Black mothers

by Truveta Research | Feb 7, 2023 | Research, Research Insights

Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women.  Maternal health outcomes in the US are worse than in many other high-income countries such as England, France,...
Truveta research published in Frontiers in Public Health

Truveta research published in Frontiers in Public Health

by Truveta Staff | Jan 18, 2023 | News, Research

In November, Truveta Research shared their findings on racial disparities in treatment and hospitalization during different periods of time of the COVID-19 pandemic.   Now, the peer-reviewed paper, “Racial inequality in COVID treatment and in-hospital length of...
Monitoring RSV: What we saw in rates of RSV hospitalization this year

Monitoring RSV: What we saw in rates of RSV hospitalization this year

by Truveta Research | Jan 13, 2023 | Research, Research Insights

Intended for a scientific audience, Truveta Research Technical Reports are a new way of looking at the timely, representative, and de-identified data in Truveta Studio. The Truveta Research blog will surface insights shown in these Technical Reports for a broader...
« Older Entries

Share this


Recent posts

  • First real-world comparative effectiveness study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
  • Beyond claims data: Truveta showcases potential of EHR data at ISPOR EU 2023
  • Reflections from the inaugural Truveta Symposium

Follow Truveta


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.